|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
 |
Nicobrevin for smoking cessationStead LF, Lancaster T
Bookmark this:
     more ...
SummaryDoes nicobrevin help people to stop smokingNicobrevin is a proprietary product containing quinine, menthyl valerate, camphor and eucalyptus oil marketed as an aid to smoking cessation. No randomized trials with long term follow up of smoking status were identified, so there was no evidence to assess efficacy.
This is a Cochrane review abstract and plain language summary, prepared and maintained by The Cochrane Collaboration, currently published in The Cochrane Database of Systematic Reviews 2010 Issue 1, Copyright © 2010 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).
This version first published online:
April 19. 2006 AbstractBackgroundNicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil. ObjectivesThe objective of this review was to assess the effects of Nicobrevin on long term smoking cessation Search strategyWe searched the Cochrane Tobacco Addiction Group trials register. Most recent search was January 2009. Selection criteriaRandomized trials comparing Nicobrevin to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow up. Data collection and analysisData were sought on the outcome, method of randomization, and completeness of follow up. Main resultsWe identified no trials meeting the full inclusion criteria including long-term follow up. Authors' conclusionsThere is no evidence available from long-term trials that Nicobrevin can aid smoking cessation. |